BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: de Lecea L, Huerta R. Hypocretin (orexin) regulation of sleep-to-wake transitions. Front Pharmacol. 2014;5:16. [PMID: 24575043 DOI: 10.3389/fphar.2014.00016] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Urbano FJ, Bisagno V, Garcia-Rill E. Arousal and drug abuse. Behav Brain Res 2017;333:276-81. [PMID: 28729115 DOI: 10.1016/j.bbr.2017.07.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
2 Wenger Combremont AL, Bayer L, Dupré A, Mühlethaler M, Serafin M. Slow Bursting Neurons of Mouse Cortical Layer 6b Are Depolarized by Hypocretin/Orexin and Major Transmitters of Arousal. Front Neurol 2016;7:88. [PMID: 27379007 DOI: 10.3389/fneur.2016.00088] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
3 Montesano A, Baumgart M, Avallone L, Castaldo L, Lucini C, Tozzini ET, Cellerino A, D'Angelo L, de Girolamo P. Age-related central regulation of orexin and NPY in the short-lived African killifish Nothobranchius furzeri. J Comp Neurol 2019;527:1508-26. [PMID: 30666646 DOI: 10.1002/cne.24638] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
4 Boss C, Roch C. Orexin research: patent news from 2016. Expert Opinion on Therapeutic Patents 2017;27:1123-33. [DOI: 10.1080/13543776.2017.1344221] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
5 Postnova S. Sleep Modelling across Physiological Levels. Clocks Sleep 2019;1:166-84. [PMID: 33089162 DOI: 10.3390/clockssleep1010015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
6 Cohen S, Matar MA, Vainer E, Zohar J, Kaplan Z, Cohen H. Significance of the orexinergic system in modulating stress-related responses in an animal model of post-traumatic stress disorder. Transl Psychiatry 2020;10:10. [PMID: 32066707 DOI: 10.1038/s41398-020-0698-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
7 Leonard CS, Ishibashi M. Orexin Receptor Functions in the Ascending Arousal System. In: Sakurai T, Pandi-perumal S, Monti JM, editors. Orexin and Sleep. Cham: Springer International Publishing; 2015. pp. 67-80. [DOI: 10.1007/978-3-319-23078-8_5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
8 Sharma A, Das S, Sur S, Tiwari J, Chaturvedi K, Agarwal N, Malik S, Rani S, Kumar V. Photoperiodically driven transcriptome-wide changes in the hypothalamus reveal transcriptional differences between physiologically contrasting seasonal life-history states in migratory songbirds. Sci Rep 2021;11:12823. [PMID: 34140553 DOI: 10.1038/s41598-021-91951-4] [Reference Citation Analysis]
9 Buzsáki G, Stark E, Berényi A, Khodagholy D, Kipke DR, Yoon E, Wise KD. Tools for probing local circuits: high-density silicon probes combined with optogenetics. Neuron 2015;86:92-105. [PMID: 25856489 DOI: 10.1016/j.neuron.2015.01.028] [Cited by in Crossref: 213] [Cited by in F6Publishing: 130] [Article Influence: 30.4] [Reference Citation Analysis]
10 Romigi A, Vitrani G, Lo Giudice T, Centonze D, Franco V. Profile of pitolisant in the management of narcolepsy: design, development, and place in therapy. Drug Des Devel Ther 2018;12:2665-75. [PMID: 30214155 DOI: 10.2147/DDDT.S101145] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 5.3] [Reference Citation Analysis]
11 Stern AL, Naidoo N. Wake-active neurons across aging and neurodegeneration: a potential role for sleep disturbances in promoting disease. Springerplus 2015;4:25. [PMID: 25635245 DOI: 10.1186/s40064-014-0777-6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
12 Luppi AI, Spindler LRB, Menon DK, Stamatakis EA. The Inert Brain: Explaining Neural Inertia as Post-anaesthetic Sleep Inertia. Front Neurosci 2021;15:643871. [PMID: 33737863 DOI: 10.3389/fnins.2021.643871] [Reference Citation Analysis]
13 Pino MF, Divoux A, Simmonds AV, Smith SR, Sparks LM. Investigating the effects of Orexin-A on thermogenesis in human deep neck brown adipose tissue. Int J Obes 2017;41:1646-53. [DOI: 10.1038/ijo.2017.155] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
14 Tesoriero C, Del Gallo F, Bentivoglio M. Sleep and brain infections. Brain Res Bull 2019;145:59-74. [PMID: 30016726 DOI: 10.1016/j.brainresbull.2018.07.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
15 Morse AM, Kothare SV. Sleep disorders and concussion. Sports Neurology. Elsevier; 2018. pp. 127-34. [DOI: 10.1016/b978-0-444-63954-7.00013-6] [Cited by in Crossref: 7] [Article Influence: 1.8] [Reference Citation Analysis]
16 Cengiz M, Karaj V, Kocabasoğlu N, Gozubatik-celik G, Dirican A, Bayoglu B. Orexin/hypocretin receptor, Orx 1 , gene variants are associated with major depressive disorder. International Journal of Psychiatry in Clinical Practice 2019;23:114-21. [DOI: 10.1080/13651501.2018.1551549] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
17 Garcia-Rill E, Luster B, D'Onofrio S, Mahaffey S, Bisagno V, Urbano FJ. Pedunculopontine arousal system physiology - Deep brain stimulation (DBS). Sleep Sci 2015;8:153-61. [PMID: 26779322 DOI: 10.1016/j.slsci.2015.09.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
18 Wenger Combremont AL, Bayer L, Dupré A, Mühlethaler M, Serafin M. Effects of Hypocretin/Orexin and Major Transmitters of Arousal on Fast Spiking Neurons in Mouse Cortical Layer 6B. Cereb Cortex 2016;26:3553-62. [PMID: 27235100 DOI: 10.1093/cercor/bhw158] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
19 Azuma K, Mishima S, Shimoyama K, Ishii Y, Ueda Y, Sakurai M, Morinaga K, Fujikawa T, Oda J. Validation of the Prediction of Delirium for Intensive Care model to predict subsyndromal delirium. Acute Med Surg 2019;6:54-9. [PMID: 30651998 DOI: 10.1002/ams2.378] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
20 Bocian R, Kazmierska P, Kłos-Wojtczak P, Kowalczyk T, Konopacki J. Orexinergic theta rhythm in the rat hippocampal formation: In vitro and in vivo findings. Hippocampus 2015;25:1393-406. [PMID: 25820995 DOI: 10.1002/hipo.22459] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
21 Moorman DE, James MH, Kilroy EA, Aston-Jones G. Orexin/hypocretin neuron activation is correlated with alcohol seeking and preference in a topographically specific manner. Eur J Neurosci 2016;43:710-20. [PMID: 26750264 DOI: 10.1111/ejn.13170] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 7.3] [Reference Citation Analysis]
22 Zhang LN, Yang C, Ouyang PR, Zhang ZC, Ran MZ, Tong L, Dong HL, Liu Y. Orexin-A facilitates emergence of the rat from isoflurane anesthesia via mediation of the basal forebrain. Neuropeptides. 2016;58:7-14. [PMID: 26919917 DOI: 10.1016/j.npep.2016.02.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
23 Colavito V, Tesoriero C, Wirtu AT, Grassi-zucconi G, Bentivoglio M. Limbic thalamus and state-dependent behavior: The paraventricular nucleus of the thalamic midline as a node in circadian timing and sleep/wake-regulatory networks. Neuroscience & Biobehavioral Reviews 2015;54:3-17. [DOI: 10.1016/j.neubiorev.2014.11.021] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 7.0] [Reference Citation Analysis]
24 Chrobok L, Palus K, Lewandowski MH. Orexins excite ventrolateral geniculate nucleus neurons predominantly via OX2 receptors. Neuropharmacology 2016;103:236-46. [DOI: 10.1016/j.neuropharm.2015.12.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
25 Ruan HZ, Wang LQ, Yuan F, Weng SJ, Zhong YM. Orexin-A differentially modulates inhibitory and excitatory synaptic transmission in rat inner retina. Neuropharmacology 2021;187:108492. [PMID: 33582153 DOI: 10.1016/j.neuropharm.2021.108492] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Zhang B, Guo D, Han L, Rensing N, Satoh A, Wong M. Hypothalamic orexin and mechanistic target of rapamycin activation mediate sleep dysfunction in a mouse model of tuberous sclerosis complex. Neurobiol Dis 2020;134:104615. [PMID: 31605778 DOI: 10.1016/j.nbd.2019.104615] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
27 Brodnik ZD, Alonso IP, Xu W, Zhang Y, Kortagere S, España RA. Hypocretin receptor 1 involvement in cocaine-associated behavior: Therapeutic potential and novel mechanistic insights. Brain Res 2020;1731:145894. [PMID: 30071195 DOI: 10.1016/j.brainres.2018.07.027] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
28 Inutsuka A, Yamashita A, Chowdhury S, Nakai J, Ohkura M, Taguchi T, Yamanaka A. The integrative role of orexin/hypocretin neurons in nociceptive perception and analgesic regulation. Sci Rep 2016;6:29480. [PMID: 27385517 DOI: 10.1038/srep29480] [Cited by in Crossref: 62] [Cited by in F6Publishing: 55] [Article Influence: 10.3] [Reference Citation Analysis]
29 Al-Kuraishy HM, Abdulhadi MH, Hussien NR, Al-Niemi MS, Rasheed HA, Al-Gareeb AI. Involvement of orexinergic system in psychiatric and neurodegenerative disorders: A scoping review. Brain Circ 2020;6:70-80. [PMID: 33033776 DOI: 10.4103/bc.bc_42_19] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
30 Shukla C, Basheer R. Metabolic signals in sleep regulation: recent insights. Nat Sci Sleep 2016;8:9-20. [PMID: 26793010 DOI: 10.2147/NSS.S62365] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
31 Liblau RS, Vassalli A, Seifinejad A, Tafti M. Hypocretin (orexin) biology and the pathophysiology of narcolepsy with cataplexy. Lancet Neurol 2015;14:318-28. [PMID: 25728441 DOI: 10.1016/S1474-4422(14)70218-2] [Cited by in Crossref: 107] [Cited by in F6Publishing: 34] [Article Influence: 15.3] [Reference Citation Analysis]
32 Firouzabadi N, Navabzadeh N, Moghimi-Sarani E, Haghnegahdar M. Orexin/Hypocretin Type 2 Receptor (HCRTR2) Gene as a Candidate Gene in Sertraline-Associated Insomnia in Depressed Patients. Neuropsychiatr Dis Treat 2020;16:1121-8. [PMID: 32440126 DOI: 10.2147/NDT.S250141] [Reference Citation Analysis]
33 de Lecea L. Optogenetic control of hypocretin (orexin) neurons and arousal circuits. Curr Top Behav Neurosci 2015;25:367-78. [PMID: 25502546 DOI: 10.1007/7854_2014_364] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
34 Fonseca EM, Vicente MC, Fournier S, Kinkead R, Bícego KC, Gargaglioni LH. Influence of light/dark cycle and orexins on breathing control in green iguanas (Iguana iguana). Sci Rep 2020;10:22105. [PMID: 33328521 DOI: 10.1038/s41598-020-79107-2] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Calderon DP, Kilinc M, Maritan A, Banavar JR, Pfaff D. Generalized CNS arousal: An elementary force within the vertebrate nervous system. Neurosci Biobehav Rev 2016;68:167-76. [PMID: 27216213 DOI: 10.1016/j.neubiorev.2016.05.014] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
36 Zhou WL, Gao XB, Picciotto MR. Acetylcholine Acts through Nicotinic Receptors to Enhance the Firing Rate of a Subset of Hypocretin Neurons in the Mouse Hypothalamus through Distinct Presynaptic and Postsynaptic Mechanisms.. eNeuro 2015;2:e0052. [PMID: 26322330 DOI: 10.1523/ENEURO.0052-14.2015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
37 Cascella M, Bimonte S, Di Napoli R. Delayed Emergence from Anesthesia: What We Know and How We Act. Local Reg Anesth 2020;13:195-206. [PMID: 33177867 DOI: 10.2147/LRA.S230728] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
38 Cerri M, Del Vecchio F, Mastrotto M, Luppi M, Martelli D, Perez E, Tupone D, Zamboni G, Amici R. Enhanced slow-wave EEG activity and thermoregulatory impairment following the inhibition of the lateral hypothalamus in the rat. PLoS One 2014;9:e112849. [PMID: 25398141 DOI: 10.1371/journal.pone.0112849] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
39 Stanojlovic M, Pallais JP, Kotz CM. Chemogenetic Modulation of Orexin Neurons Reverses Changes in Anxiety and Locomotor Activity in the A53T Mouse Model of Parkinson's Disease. Front Neurosci 2019;13:702. [PMID: 31417337 DOI: 10.3389/fnins.2019.00702] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
40 Li SB, Giardino WJ, de Lecea L. Hypocretins and Arousal. Curr Top Behav Neurosci 2017;33:93-104. [PMID: 28012091 DOI: 10.1007/7854_2016_58] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
41 Cascella M, Bimonte S, Muzio MR. Towards a better understanding of anesthesia emergence mechanisms: Research and clinical implications. World J Methodol 2018; 8(2): 9-16 [PMID: 30345225 DOI: 10.5662/wjm.v8.i2.9] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
42 Zimmerman JE, Chan MT, Lenz OT, Keenan BT, Maislin G, Pack AI. Glutamate Is a Wake-Active Neurotransmitter in Drosophila melanogaster. Sleep 2017;40. [PMID: 28364503 DOI: 10.1093/sleep/zsw046] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
43 Kostin A, Alam MA, McGinty D, Alam MN. Adult hypothalamic neurogenesis and sleep-wake dysfunction in aging. Sleep 2021;44:zsaa173. [PMID: 33202015 DOI: 10.1093/sleep/zsaa173] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
44 Nixon JP, Mavanji V, Butterick TA, Billington CJ, Kotz CM, Teske JA. Sleep disorders, obesity, and aging: the role of orexin. Ageing Res Rev 2015;20:63-73. [PMID: 25462194 DOI: 10.1016/j.arr.2014.11.001] [Cited by in Crossref: 71] [Cited by in F6Publishing: 57] [Article Influence: 10.1] [Reference Citation Analysis]
45 Feng P, Akladious AA, Hu Y, Raslan Y, Feng J, Smith PJ. 7,8-Dihydroxyflavone reduces sleep during dark phase and suppresses orexin A but not orexin B in mice. J Psychiatr Res 2015;69:110-9. [PMID: 26343602 DOI: 10.1016/j.jpsychires.2015.08.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
46 Kushikata T, Sawada M, Niwa H, Kudo T, Kudo M, Tonosaki M, Hirota K. Ketamine and propofol have opposite effects on postanesthetic sleep architecture in rats: relevance to the endogenous sleep-wakefulness substances orexin and melanin-concentrating hormone. J Anesth 2016;30:437-43. [PMID: 26984688 DOI: 10.1007/s00540-016-2161-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
47 Inutsuka A, Inui A, Tabuchi S, Tsunematsu T, Lazarus M, Yamanaka A. Concurrent and robust regulation of feeding behaviors and metabolism by orexin neurons. Neuropharmacology 2014;85:451-60. [PMID: 24951857 DOI: 10.1016/j.neuropharm.2014.06.015] [Cited by in Crossref: 75] [Cited by in F6Publishing: 66] [Article Influence: 9.4] [Reference Citation Analysis]
48 Vermeeren A, Sun H, Vuurman EF, Jongen S, Van Leeuwen CJ, Van Oers AC, Palcza J, Li X, Laethem T, Heirman I, Bautmans A, Troyer MD, Wrishko R, McCrea J. On-the-Road Driving Performance the Morning after Bedtime Use of Suvorexant 20 and 40 mg: A Study in Non-Elderly Healthy Volunteers. Sleep 2015;38:1803-13. [PMID: 26039969 DOI: 10.5665/sleep.5168] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 4.7] [Reference Citation Analysis]
49 Stanojlovic M, Pallais Yllescas JP Jr, Mavanji V, Kotz C. Chemogenetic activation of orexin/hypocretin neurons ameliorates aging-induced changes in behavior and energy expenditure. Am J Physiol Regul Integr Comp Physiol 2019;316:R571-83. [PMID: 30726119 DOI: 10.1152/ajpregu.00383.2018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
50 Kumar S, Behl T, Sehgal A, Singh S, Sharma N, Bhatia S, Al-Harassi A, Abdel-Daim MM, Bungau S. Exploring the Role of Orexinergic Neurons in Parkinson's Disease. Neurotox Res 2021. [PMID: 34495449 DOI: 10.1007/s12640-021-00411-4] [Reference Citation Analysis]
51 Laperchia C, Imperatore R, Azeez IA, Del Gallo F, Bertini G, Grassi-Zucconi G, Cristino L, Bentivoglio M. The excitatory/inhibitory input to orexin/hypocretin neuron soma undergoes day/night reorganization. Brain Struct Funct 2017;222:3847-59. [PMID: 28669028 DOI: 10.1007/s00429-017-1466-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
52 Sheng Q, Xue Y, Wang Y, Chen AQ, Liu C, Liu YH, Chu HY, Chen L. The Subthalamic Neurons are Activated by Both Orexin-A and Orexin-B. Neuroscience 2018;369:97-108. [PMID: 29138106 DOI: 10.1016/j.neuroscience.2017.11.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
53 Wang D, Guo Y, Li H, Li J, Ran M, Guo J, Yin L, Zhao S, Yang Q, Dong H. Selective optogenetic activation of orexinergic terminals in the basal forebrain and locus coeruleus promotes emergence from isoflurane anaesthesia in rats. Br J Anaesth 2021;126:279-92. [PMID: 33131759 DOI: 10.1016/j.bja.2020.09.037] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
54 Azuma K, Takaesu Y, Soeda H, Iguchi A, Uchida K, Ohta S, Mishima S, Inoue T, Inoue Y, Oda J. Ability of suvorexant to prevent delirium in patients in the intensive care unit: a randomized controlled trial. Acute Med Surg 2018;5:362-8. [PMID: 30338083 DOI: 10.1002/ams2.368] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
55 Chrobok L, Palus-Chramiec K, Chrzanowska A, Kepczynski M, Lewandowski MH. Multiple excitatory actions of orexins upon thalamo-cortical neurons in dorsal lateral geniculate nucleus - implications for vision modulation by arousal. Sci Rep 2017;7:7713. [PMID: 28794459 DOI: 10.1038/s41598-017-08202-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
56 Mosqueiro T, de Lecea L, Huerta R. Control of sleep-to-wake transitions via fast aminoacid and slow neuropeptide transmission. New J Phys 2014;16:115010. [PMID: 25598695 DOI: 10.1088/1367-2630/16/11/115010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
57 Palomba M, Seke-Etet PF, Laperchia C, Tiberio L, Xu YZ, Colavito V, Grassi-Zucconi G, Bentivoglio M. Alterations of orexinergic and melanin-concentrating hormone neurons in experimental sleeping sickness. Neuroscience 2015;290:185-95. [PMID: 25595977 DOI: 10.1016/j.neuroscience.2014.12.066] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
58 Vermeeren A, Vets E, Vuurman EF, Van Oers AC, Jongen S, Laethem T, Heirman I, Bautmans A, Palcza J, Li X, Troyer MD, Wrishko R, McCrea J, Sun H. On-the-road driving performance the morning after bedtime use of suvorexant 15 and 30 mg in healthy elderly. Psychopharmacology (Berl) 2016;233:3341-51. [PMID: 27424295 DOI: 10.1007/s00213-016-4375-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
59 Palus K, Chrobok L, Lewandowski M. Orexins/hypocretins modulate the activity of NPY-positive and -negative neurons in the rat intergeniculate leaflet via OX1 and OX2 receptors. Neuroscience 2015;300:370-80. [DOI: 10.1016/j.neuroscience.2015.05.039] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
60 Brodnik ZD, Bernstein DL, Prince CD, España RA. Hypocretin receptor 1 blockade preferentially reduces high effort responding for cocaine without promoting sleep. Behav Brain Res 2015;291:377-84. [PMID: 26049058 DOI: 10.1016/j.bbr.2015.05.051] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
61 Stanojlovic M, Pallais JP, Kotz CM. Inhibition of Orexin/Hypocretin Neurons Ameliorates Elevated Physical Activity and Energy Expenditure in the A53T Mouse Model of Parkinson's Disease. Int J Mol Sci 2021;22:E795. [PMID: 33466831 DOI: 10.3390/ijms22020795] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Joshi D, Singh SK. The neuropeptide orexin A - search for its possible role in regulation of steroidogenesis in adult mice testes. Andrology 2018;6:465-77. [DOI: 10.1111/andr.12475] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
63 Stanojlovic M, Pallais Yllescas JP Jr, Vijayakumar A, Kotz C. Early Sociability and Social Memory Impairment in the A53T Mouse Model of Parkinson's Disease Are Ameliorated by Chemogenetic Modulation of Orexin Neuron Activity. Mol Neurobiol 2019;56:8435-50. [PMID: 31250383 DOI: 10.1007/s12035-019-01682-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
64 Steiner MA, Winrow CJ. Opportunities and perspectives for developing orexin receptor antagonists. Front Neurosci 2014;8:158. [PMID: 24971050 DOI: 10.3389/fnins.2014.00158] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
65 Laperchia C, Xu YZ, Mumba Ngoyi D, Cotrufo T, Bentivoglio M. Neural Damage in Experimental Trypanosoma brucei gambiense Infection: Hypothalamic Peptidergic Sleep and Wake-Regulatory Neurons. Front Neuroanat 2018;12:13. [PMID: 29535612 DOI: 10.3389/fnana.2018.00013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
66 Vermeeren A, Jongen S, Murphy P, Moline M, Filippov G, Pinner K, Perdomo C, Landry I, Majid O, Van Oers ACM, Van Leeuwen CJ, Ramaekers JG, Vuurman EFPM. On-the-road driving performance the morning after bedtime administration of lemborexant in healthy adult and elderly volunteers. Sleep 2019;42:zsy260. [PMID: 30597112 DOI: 10.1093/sleep/zsy260] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 12.0] [Reference Citation Analysis]
67 Antelmi E, Ferri R, Iranzo A, Arnulf I, Dauvilliers Y, Bhatia KP, Liguori R, Schenck CH, Plazzi G. From state dissociation to status dissociatus. Sleep Medicine Reviews 2016;28:5-17. [DOI: 10.1016/j.smrv.2015.07.003] [Cited by in Crossref: 33] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
68 Tristan I, Rulkov NF, Huerta R, Rabinovich M. Timing control by redundant inhibitory neuronal circuits. Chaos 2014;24:013124. [PMID: 24697386 DOI: 10.1063/1.4866580] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
69 Joiner WJ. The Neurobiological Basis of Sleep and Sleep Disorders. Physiology (Bethesda) 2018;33:317-27. [PMID: 30109824 DOI: 10.1152/physiol.00013.2018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
70 Waters K. Review of the Efficacy and Safety of Lemborexant, a Dual Receptor Orexin Antagonist (DORA), in the Treatment of Adults With Insomnia Disorder. Ann Pharmacother 2021;:10600280211008492. [PMID: 34078141 DOI: 10.1177/10600280211008492] [Reference Citation Analysis]
71 Xue T, Wu X, Chen S, Yang Y, Yan Z, Song Z, Zhang W, Zhang J, Chen Z, Wang Z. The efficacy and safety of dual orexin receptor antagonists in primary insomnia: A systematic review and network meta-analysis. Sleep Med Rev 2021;61:101573. [PMID: 34902823 DOI: 10.1016/j.smrv.2021.101573] [Reference Citation Analysis]